UNSPSC 51171519: Attapulgite

This classification denotes an antidiarrheal agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U6V729APAM. European Medicines Agency schedules Attapulgite in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12962MIG. Attapulgite generally arises in the molecular formula AL.MG.10O.4SI.HO.4H2O. The term 'attapulgite' is an FDA designation. As of Q4 2014, ATTAPULGITE remains the US FDA Preferred Term for this commodity. Attapulgite bears US NLM identifiers UMLS ID C0052657 and NCI Concept Code C28841.

SMILES: O.O.O.O.O.O.O.O.O.O.O.O.O.O.[OH-].[MG].[MG].[AL].[AL].[SI].[SI].[SI].[SI]..

UNSPSC 51171519 Attapulgite is a Commodity code that sits at the lowest tier of the taxonomy, but the recent state and local opportunities do not reflect procurement of attapulgite—a naturally occurring clay mineral used primarily in industrial applications such as absorbents, drilling fluids, and filtration media. Instead, the three recent opportunities tagged under this code involve specimen collection and drug testing services, direct-to-manufacturer pharmacy programs, and generic pharmaceutical and over-the-counter product distribution through cooperative purchasing. These solicitations do not align with the scope of attapulgite itself, indicating a mismatch between the UNSPSC code assignment and the actual work being procured.

The recent contract opportunities show minimal relevant activity under this code. The issuing bodies include Collin County, Texas (Community Supervision and Corrections Department), the Texas Health and Human Services Commission, and the Minnesota Department of Administration's Office of State Procurement on behalf of MMCAP (a multistate cooperative purchasing alliance). Geographic activity centers on Texas and Minnesota, with Oregon participating in the MMCAP cooperative. The Collin County RFP for offender specimen collection and drug testing services (Solicitation 2026-327, response due July 23, 2026, estimated contract value $600,000 over two years) is the only opportunity with clear procurement details and timeline. The Texas HHS RFI (HHS0017013, posted April 3, 2026) and the MMCAP RFP for generic pharmaceuticals (S1070000015802, due March 26, 2026) represent market research and cooperative purchasing activity unrelated to attapulgite procurement. The code shows no recent state and local opportunities for attapulgite itself; firms pursuing this code should evaluate whether their products or services match the pharmaceutical and human services testing focus currently tagged under it, or confirm that the taxonomy assignment is in error.